0KBL Stock Overview
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 1/6 |
Dividends | 4/6 |
Rewards
Risk Analysis
Omega Healthcare Investors, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$30.07 |
52 Week High | US$34.77 |
52 Week Low | US$26.16 |
Beta | 0.90 |
1 Month Change | -3.23% |
3 Month Change | 1.59% |
1 Year Change | 12.92% |
3 Year Change | -21.21% |
5 Year Change | -19.88% |
Change since IPO | 9.70% |
Recent News & Updates
Recent updates
Shareholder Returns
0KBL | GB Health Care REITs | GB Market | |
---|---|---|---|
7D | -2.3% | -2.4% | -1.4% |
1Y | 12.9% | -16.1% | -2.4% |
Return vs Industry: 0KBL exceeded the UK Health Care REITs industry which returned -14.9% over the past year.
Return vs Market: 0KBL exceeded the UK Market which returned -1% over the past year.
Price Volatility
0KBL volatility | |
---|---|
0KBL Average Weekly Movement | 3.1% |
Health Care REITs Industry Average Movement | 2.8% |
Market Average Movement | 4.9% |
10% most volatile stocks in GB Market | 11.5% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0KBL has not had significant price volatility in the past 3 months.
Volatility Over Time: 0KBL's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1992 | 57 | C. Pickett | www.omegahealthcare.com |
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
Omega Healthcare Investors, Inc. Fundamentals Summary
0KBL fundamental statistics | |
---|---|
Market cap | US$7.56b |
Earnings (TTM) | US$242.18m |
Revenue (TTM) | US$949.74m |
30.3x
P/E Ratio7.7x
P/S RatioIs 0KBL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0KBL income statement (TTM) | |
---|---|
Revenue | US$949.74m |
Cost of Revenue | US$59.58m |
Gross Profit | US$890.16m |
Other Expenses | US$647.98m |
Earnings | US$242.18m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.99 |
Gross Margin | 93.73% |
Net Profit Margin | 25.50% |
Debt/Equity Ratio | 134.9% |
How did 0KBL perform over the long term?
See historical performance and comparison